rk-582
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 13, 2025 (NCT06853496)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 1 Sponsor(trial)
Mechanism of action
- Proto-oncogene Wnt-1INHIBITOR
WNT1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06853496 | Phase 1 | Mar 13, 2025 | Japan Agency for Medical Research and Development, Japanese Foundation for Cancer Research, The Cancer Institute Hospital of JFCR |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Japan Agency for Medical Research and Development | Government | 1 | 0 | 1 | 2025 |
| Japanese Foundation for Cancer Research | Academic/Hospital | 1 | 1 | 1 | 2025 |
| The Cancer Institute Hospital of JFCR | Academic/Hospital | 1 | 0 | 1 | 2025 |
3 organizations
Page 1 / 1